Author

L. Fernandez-Cuesta

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:statistical model· 2 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

M. Foll· 3 shared N. Alcala· 3 shared A. Sexton-Oates· 2 shared C. Voegele· 2 shared H. Clevers· 2 shared L. Mangiante· 2 shared T. L. Dayton· 2 shared A. F. M. Dost· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

M. Foll

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivAug 31, 2023

Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms

N. Alcala, C. Voegele, L. Mangiante…·M. Foll

The paper presents a multi-omic dataset of patient-derived tumor organoids for neuroendocrine neoplasms, including whole-genome and RNA-seq data, and provides analysis tools for re-use.

DOI 10.1093/gigascience/giae008

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivOct 31, 2022

Druggable Growth Dependencies and Tumor Evolution Analysis in Patient-Derived Organoids of Neuroendocrine Cancer

T. L. Dayton, N. Alcala, L. Moonen…·H. Clevers

This study establishes patient-derived tumor organoids (PDTOs) for neuroendocrine cancers, identifies therapeutic vulnerabilities, and highlights EGF dependency in pulmonary neuroendocrine tumors.

DOI 10.1016/j.ccell.2023.11.007

humanorganoid / primary culture

𝕏 PostBluesky

Cancer BiologybioRxivMay 30, 2018

Redefining mesothelioma types as a continuum uncovers the immune and vascular systems as key players in the diagnosis and prognosis of this disease

N. Alcala, C. Caux, N. Girard…·L. Fernandez-Cuesta

This study redefines mesothelioma as a continuum rather than distinct types, identifying immune and vascular pathways as key factors in prognosis and potential therapeutic targets.

DOI 10.1016/j.ebiom.2019.09.003

humanbulk RNA-seq

𝕏 PostBluesky